US Patent 8476284 Inhibitors of Bruton's tyrosine kinase
Patent 8476284 was granted and assigned to Pharmacyclics on July, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+89 characters)
Article
Patent abstract
Disclosed herein are compounds, including compounds having the Formula (A)
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08476284 Inhibitors of Bruton's tyrosine kinase US Patent 8476284 Inhibitors of Bruton's tyrosine kinase
Infobox
Patent Number
0847628400
Patent Number
847628400
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084762840
Date of Patent
July 2, 2013
0Patent Application Number
133287180
Date Filed
December 16, 2011
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084762840
Date of Patent
July 2, 2013
0Patent Application Number
133287180
Date Filed
December 16, 2011
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08476284 Inhibitors of Bruton's tyrosine kinase
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08476284
Date of patent
July 2, 2013
Patent application number
13328718
Date Filed
December 16, 2011
Patent primary examiner
Find more entities like US Patent 8476284 Inhibitors of Bruton's tyrosine kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
